Effect of a aingle i.v. infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoidinduced osteoporosis

Autor:	Chak Sing Lau, Jean-Pierre Devogelaer, Jacques Reginster, Peter Mesenbrink, C. Roux, Kenneth G. Saag, O. Schoenborn-Kellenberger, D.M. Reid, K. Maylandt, Philip N. Sambrook, T. Fashola, Philemon Papanastasiou
Rok vydání:	2009
Předmět:	medicine.medical_specialty Histology Physiology business.industry Endocrinology Diabetes and Metabolism Osteoporosis medicine.disease Bone remodeling Surgery Endocrinology Zoledronic acid Internal medicine medicine I v infusion In patient business Glucocorticoid medicine.drug
Zdroj:	Bone. 44:S96
ISSN:	8756-3282
DOI:	10.1016/j.bone.2009.01.421
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::833301d13301904252c7b7a4a22b972f https://doi.org/10.1016/j.bone.2009.01.421 Zobrazit plný text záznamu Full Text from ScienceDirect